Prediabetes management in the Middle East, Africa and Russia: Current status and call for action

Author:

Assaad Khalil Samir Helmy1,Abdelaziz Sulaf Ibrahim2,Al Shammary Affaf3,Al Zahrani Ali4,Amir Ashraf5,Elkafrawy Nabil6,Hassoun Ahmed AK7,Hostalek Ulrike8,Jahed Adel910,Jarrah Nadim11,Mrabeti Sanaa12,Paruk Imran13,Zilov Alexey V14

Affiliation:

1. Unit of Diabetology, Lipidology & Metabolism, Department of Internal Medicine, Alexandria Faculty of Medicine, Alexandria University, Alexandria, Egypt

2. Department of Internal Medicine and Endocrinology, Soba University Hospital, University of Khartoum, Khartoum, Sudan

3. International Health Department, Ministry of Health, Riyadh, Kingdom of Saudi Arabia

4. Medicine and Molecular Endocrinology Section, Department of Molecular Oncology, King Faisal Specialist Hospital & Research Centre, Riyadh, Kingdom of Saudi Arabia

5. Department of Family Medicine, International Medical Center, Jeddah, Kingdom of Saudi Arabia

6. Egyptian National Committee of Diabetes, Department of Internal Medicine and Diabetology, Menoufia University, Al Menoufia, Egypt

7. Dubai Diabetes Center, Dubai, UAE

8. Merck KGaA, Darmstadt, Germany

9. Diabetes Education Advisory Committee, Gabric Diabetes Education Association, Tehran, Iran

10. Tehran General Hospital, Tehran, Iran

11. Internal Medicine Department, The Specialty Hospital, Amman, Jordan

12. Merck Serono Middle East FZ-LLC, Dubai, UAE

13. University of KwaZulu-Natal, Durban, South Africa

14. Department of Endocrinology, Sechenov’s First Moscow Medical University, Moscow, Russia

Abstract

Most data on the burden of diabetes and prediabetes are from countries where local infrastructure can support reliable estimates of the burden of non-communicable diseases. Countries in the Middle East and Africa, together with Russia, have a total population of almost 2 billion, but have been relatively overlooked by authors in this field. We reviewed the prevalence and drivers of prediabetes and diabetes across this large region. A large, and variable, burden of dysglycaemia exists, especially in Middle Eastern and North African countries, associated with high levels of obesity and sedentariness, with a generally lower prevalence in most other parts of Africa. The design and size of studies are highly variable, and more research to quantify the scale of the problem is needed. Local barriers to care relating to issues concerned with gender, consanguinity, lack of understanding of diabetes, lack of understanding of obesity as a health issue, and limited resource at a national level for tracking and intervention for diabetes and other non-communicable diseases. Lifestyle interventions with proven local cost-effectiveness, enhanced access to pharmacologic intervention, and societal interventions to promote better diet and more activity will be an important element in strategies to combat these adverse trends.

Publisher

SAGE Publications

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3